ClinicalTrials.gg
RecruitingNCT07894575Updated Oct 26, 2026

Impact of Septoplasty on Headache

An interventional study of Septoplasty in Impact of Septoplasty on Headache, sponsored by Sohag University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Updated Oct 26, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Impact of septoplasty on headache if there is improvement or changes in headache severity before and after operation

02

Conditions studied

  • Impact of Septoplasty on Headache

Browse trials for

Keywords

  • Septoplasty; headache
03

In context

Headache

1,235 studies on the registry are indexed under Headache; 201 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 926 interventional studies indexed under Headache.

Browse Headache studies →

Lead sponsor

Sohag University is the lead sponsor of 1,220 studies on the registry; 629 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. age [18 - 60] years
  2. patients who have septal deviation and headache

Exclusion criteria

Exclusion Criteria:

  1. Nasal diseases as Allergic rhinitis , Acute and chronic sinusitis , Nasal Polyps , granulomatous diseases , septal perforation
  2. Past history of nasal surgery
  3. systemic diseases as hypertension , diabetes , anemia , Blood diseases
  4. ophthalomological causes : Glaucoma ; Refractive errors.
  5. cervical spine and temporomandibular joint problems
  6. congential anomalies as Cleft lips or palate
  7. neurological causes: vascular headache; tension headache; cluster headache ; migraine ; stroke ; epilepsy; tumors.
  8. dental causes: Untreated dental caries associated with pain ; teeth grinding ; recent dental procedures ; dental inflammation or abscess

    -

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Septoplasty group

    Patients with headache who will undergo septoplasty surgical procedure for setum deviation

    Procedure: Septoplasty

Interventions

  • ProcedureSeptoplasty

    Surgical correction of the deviated nasal septum and evaluate its clinical impact on improving patients' headache

06

What researchers measure

Primary outcomes

  1. Change in Headache Severity before and after septoplasty

    Headache severity will be assessed using the Visual Analogue Scale (VAS), where scores range from 0 (no pain) to 10 (worst possible pain). Higher scores indicate more severe headache.

    Time frame: Preoperatively and postoperatively at 1 month ; 3 month ; 6 month

07

Study locations

1 of 1 sites recruiting
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07894575
Lead sponsor
Sohag University
Responsible party
Sara Elia Adly (Sara Elia, Sohag University) — Principal investigator
First posted
Oct 26, 2026
Start date
Aug 20, 2026
Primary completion
Aug 20, 2027 (estimated)
Completion
Aug 20, 2027 (estimated)
Last update
Oct 26, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion